Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Verona Pharma Plc LSE:VRP London Ordinary Share GB00BYW2KH80 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  4.50 12.16% 41.50 40.00 43.00 41.50 39.00 39.00 249,772 15:58:17
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -24.1 -18.9 - 44

Verona Pharma plc Update On Agm Procedure

08/04/2020 7:00am

UK Regulatory (RNS & others)


 
TIDMVRP 
 
   LONDON, April 08, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) 
(Nasdaq: VRNA) ("Verona Pharma" or the "Company"), a clinical-stage 
biopharmaceutical company focused on developing and commercializing 
innovative therapies for respiratory diseases, provides an update on its 
upcoming Annual General Meeting ("AGM"), scheduled to be held at the 
offices of Shakespeare Martineau at 60 Gracechurch Street, London EC3V 
0HR, United Kingdom at 10.30 a.m. on April 16, 2020. 
 
   The Company currently plans to hold its AGM as scheduled, however given 
the UK Government's present restrictions on public gatherings of more 
than two people, the Board requests shareholders to vote by proxy rather 
than attend the AGM in person. Any shareholders seeking to attend the 
AGM in person will be refused entry. 
 
   By way of reminder, the deadline for delivery of completed proxy forms 
by holders of the Company's ordinary shares is 10.30 a.m. on April 14, 
2020. The equivalent deadline for proxy voting by holders of the 
Company's American Depository Shares is 10 a.m. on April 9, 2020. 
 
   Verona Pharma continues to review the UK Government's restrictions and 
recommends that shareholders monitor the Company's website and 
announcements for any updates in relation to the AGM. In the event that 
its AGM arrangements have to change, the Company will issue a further 
communication via a regulatory information service. 
 
   A copy of our 
https://www.globenewswire.com/Tracker?data=8Pw5dDrrYyta7egTU1c8Q0pGi-28v5Fn0lNHPqfZLvGl1jvks4H_ksJ7KdtPGyQn-2de_teBBtPSAGCBrgj9jGWzMWzLsQb9uqbdJcEhBw0uGtQgVcoB4P0dN9VM84cTxTuCVusVL2uDuLBSqIRblQUiW5T5r-79fAFZ754xxf9drRQVq9150B0gQ2fBmDCAtflsnCfkNNto5IHSztzFxH0wDNOrupr9MZl4loCLRM4= 
AGM Notice and 
https://www.globenewswire.com/Tracker?data=IYfS9qEzVhJSElJbcrFnP-UHTdCSZdhK8icpCnluDUcE1UilYF7zlClhsK_7tijJD-J_TJ8UEzmtDcm7E8JUITGmQoRlqQAbzZO1bebVYiDJAQIPJcvcTIRGlObmYjYhbnaEWgXapMErl5kLk3dFPWod9MtUfVaFAkUDW3aKwjQihyfIEdE8G3iQENHYHN8xe5DeSQPfHaYjcb0yMw5NknPZYuk8FiqgSJsigX3gCCk= 
Annual Report are available on the Company's website within the 
Investors section, www.veronapharma.com. 
 
   For further information, please contact: 
 
 
 
 
Verona Pharma plc                             Tel: +44 (0)20 3283 4200 
--------------------------------------------  ------------------------ 
Victoria Stewart, Director of Communications  info@veronapharma.com 
--------------------------------------------  ------------------------ 
 
N+1 Singer                                    Tel: +44 (0)20 3283 4200 
--------------------------------------------  ------------------------ 
(Nominated Adviser and UK Broker) 
 Aubrey Powell / George Tzimas / Iqra 
 Amin (Corporate Finance) 
 Tom Salvesen (Corporate Broking) 
--------------------------------------------  ------------------------ 
 
 
 
 
 
 

(END) Dow Jones Newswires

April 08, 2020 02:00 ET (06:00 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

1 Year Verona Pharma Chart

1 Year Verona Pharma Chart

1 Month Verona Pharma Chart

1 Month Verona Pharma Chart
ADVFN Advertorial
Your Recent History
LSE
VRP
Verona Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200528 20:30:53